1
Total investments
0
Early stage
0
Mid stage
0
Late stage
5y
Years active
Portfolio
1 investments ยท sorted by recency
All investments
Early stage
Mid stage
Late stage
Healthcare Investor & Advisor
Aug 2021
HIP - is an opportunistic venture capital firm that uses a unique multi-disciplinary collaborative ecosystem model to fund innovation in healthcare. A firm with a TRUE NORTH of conducting the most detailed and complete early stage diligence in the industry - HIP has grown to over 275 investors (including 90 institutional including 18 health system strategic investors). HIP endorses an opportunity for investment ONLY after its extensive diligence and deploys capital through its Fund and sidecar - deal by deal investment vehicle. In parallel - institutional investors in HIP deploy capital through their own structures and funds based on their independent decision but heavily weighed by the collective HIP endorsement and powerful HIP model/process.
As of late 2024 - HIP portfolio has 12 early stage healthcare technology companies. With over 75% having received multiple rounds of funding from the HIP ecosystem.
Visit our site for details to join our mission as an investor in healthcare or to seek audience for investment (fill out a short sign up form)
Experience ยท 3 entries
All (3)
Investments (1)
Founder (1)
2023
Co-founder & CEO
Apr 2023
Tip the scales against medical claim denials. Protego helps you proactively reduce insurance denials by incorporating intelligent recommendations based on payor-specific policies and coding guidelines directly into the claim creation workflow. When denials do occur, reduce the time it takes to remediate complex denials by up to 91%.
2021
Healthcare Investor & Advisor
Aug 2021
HIP - is an opportunistic venture capital firm that uses a unique multi-disciplinary collaborative ecosystem model to fund innovation in healthcare. A firm with a TRUE NORTH of conducting the most detailed and complete early stage diligence in the industry - HIP has grown to over 275 investors (including 90 institutional including 18 health system strategic investors). HIP endorses an opportunity for investment ONLY after its extensive diligence and deploys capital through its Fund and sidecar - deal by deal investment vehicle. In parallel - institutional investors in HIP deploy capital through their own structures and funds based on their independent decision but heavily weighed by the collective HIP endorsement and powerful HIP model/process.
As of late 2024 - HIP portfolio has 12 early stage healthcare technology companies. With over 75% having received multiple rounds of funding from the HIP ecosystem.
Visit our site for details to join our mission as an investor in healthcare or to seek audience for investment (fill out a short sign up form)
2017
Senior Director of Enterprise Solutions and SMB partnerships
Jan 2017
Parachute Health is modernizing healthcare through digital connectivity.
The Parachute Platform empowers healthcare providers with delightfully simple ePrescribing for medical equipment (DME), supplies, and services and powers suppliers with digital transformation tools - to streamline workflows, increase clinician satisfaction and improve patient outcomes.
ePrescribing DME on the Parachute Platform generates clean, complete orders, with no re-work required. This means fewer hassles for providers and insurers, all to enhance patient care.
To learn more and sign up for an ePrescribing account, please visit https://www.parachutehealth.com/eprescribe-ordering
DME Suppliers can join the Parachute Network at https://www.parachutehealth.com/supplier-sign-up
